Search Results 31-40 of 28166 for primary sclerosing cholangitis
No alternative medicine treatments have been found to treat primary sclerosing cholangitis. But some complementary and alternative therapies may help you ...
Primary biliary cholangitis is a type of liver disease that damages the bile ducts. Early recognition and treatment may help prevent complications.
Mayo Clinic researchers were among the first to describe primary sclerosing cholangitis. Other research done at Mayo has helped to refine diagnostic tests, ...
Basic research related to primary sclerosing cholangitis and other liver diseases is conducted in the following Mayo Clinic laboratories: Cholangiopathies ...
Primary sclerosing cholangitis, or PSC, is a condition that damages the ducts that carry digestive bile from the liver to the small intestine. Many ...
Primary biliary cholangitis is a relatively rare condition, occurring in less than 1 in 2,000 people. Mayo Clinic doctors typically see around 900 people a year ...
His research focuses on the role of genetic predisposition and genetic-environmental interactions in primary biliary cholangitis and primary sclerosing ...
... primary sclerosing cholangitis (PSC). Mayo Clinic is a pioneer of this treatment, which provides aggressive radiation and chemotherapy before transplant ...
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic biliary tract disease characterized by inflammation, fibrosis and strictures that can progress ...
A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis · Overview.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!